Hora M - Search Results

1

Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16^INK4A.

Göbl C, Morris VK, van Dam L, Visscher M, Polderman PE, Hartlmüller C, de Ruiter H, Hora M, Liesinger L, Birner-Gruenberger R, Vos HR, Reif B, Madl T, Dansen TB. Göbl C, et al. Among authors: hora m. Redox Biol. 2020 Jan;28:101316. doi: 10.1016/j.redox.2019.101316. Epub 2019 Sep 3. Redox Biol. 2020. PMID: 31539802 Free PMC article.

2

A Stable Mutant Predisposes Antibody Domains to Amyloid Formation through Specific Non-Native Interactions.

Nokwe CN, Hora M, Zacharias M, Yagi H, Peschek J, Reif B, Goto Y, Buchner J. Nokwe CN, et al. Among authors: hora m. J Mol Biol. 2016 Mar 27;428(6):1315-1332. doi: 10.1016/j.jmb.2016.01.015. Epub 2016 Jan 29. J Mol Biol. 2016. PMID: 26827727

3

The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.

Weber B, Hora M, Kazman P, Göbl C, Camilloni C, Reif B, Buchner J. Weber B, et al. Among authors: hora m. J Mol Biol. 2018 Dec 7;430(24):4925-4940. doi: 10.1016/j.jmb.2018.10.024. Epub 2018 Nov 8. J Mol Biol. 2018. PMID: 30414962

4

MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Hora M, Sarkar R, Morris V, Xue K, Prade E, Harding E, Buchner J, Reif B. Hora M, et al. PLoS One. 2017 Jul 26;12(7):e0181799. doi: 10.1371/journal.pone.0181799. eCollection 2017. PLoS One. 2017. PMID: 28746363 Free PMC article.

5

The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.

Nokwe CN, Hora M, Zacharias M, Yagi H, John C, Reif B, Goto Y, Buchner J. Nokwe CN, et al. Among authors: hora m. J Mol Biol. 2015 Nov 6;427(22):3572-3586. doi: 10.1016/j.jmb.2015.09.012. Epub 2015 Sep 25. J Mol Biol. 2015. PMID: 26408269

6

Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains.

Hora M, Carballo-Pacheco M, Weber B, Morris VK, Wittkopf A, Buchner J, Strodel B, Reif B. Hora M, et al. Sci Rep. 2017 Jan 27;7:41515. doi: 10.1038/srep41515. Sci Rep. 2017. PMID: 28128355 Free PMC article.

7

Physical basis of amyloid fibril polymorphism.

Close W, Neumann M, Schmidt A, Hora M, Annamalai K, Schmidt M, Reif B, Schmidt V, Grigorieff N, Fändrich M. Close W, et al. Among authors: hora m. Nat Commun. 2018 Feb 16;9(1):699. doi: 10.1038/s41467-018-03164-5. Nat Commun. 2018. PMID: 29453354 Free PMC article.

8

Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants.

Weber B, Hora M, Kazman P, Pradhan T, Rührnößl F, Reif B, Buchner J. Weber B, et al. Among authors: hora m. J Mol Biol. 2020 Nov 20;432(23):6187-6199. doi: 10.1016/j.jmb.2020.10.005. Epub 2020 Oct 13. J Mol Biol. 2020. PMID: 33058870

9

Solid- and solution-state nuclear magnetic resonance spectroscopic studies on antibody light chain amyloid formation and interactions with epigallocatechin gallate.

Hora M, Carballo Pacheco M, Weber B, Buchner J, Strodel B, Reif B. Hora M, et al. Amyloid. 2017 Mar;24(sup1):10. doi: 10.1080/13506129.2016.1269736. Epub 2016 Dec 26. Amyloid. 2017. PMID: 28019720 No abstract available.

10

A residue-specific shift in stability and amyloidogenicity of antibody variable domains.

Nokwe CN, Zacharias M, Yagi H, Hora M, Reif B, Goto Y, Buchner J. Nokwe CN, et al. Among authors: hora m. J Biol Chem. 2014 Sep 26;289(39):26829-26846. doi: 10.1074/jbc.M114.582247. Epub 2014 Aug 5. J Biol Chem. 2014. PMID: 25096580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters